The U.S. Food & Drug Administration's good manufacturing practice (GMP) inspections of dietary supplement facilities is back up to 500 per year, a return to pre-COVID levels, but those levels are still inadequate, says Dr. Cara Welch, FDA’s director of the Office of Dietary Supplement Programs (ODSP).